Healthcare Sales & Marketing Network News: cervical cancer screening

Searching News Database: cervical cancer screening

HSMN NewsFeed - 17 Nov 2025
BD Onclarity(TM) HPV Assay for BD COR(TM) and BD Viper(TM) LT Systems Receive WHO Prequalification
Diagnostics Regulatory

HSMN NewsFeed - 9 May 2025
FDA Approves Teal Health's Teal Wand(TM)--The First and Only At-Home Self-Collection Device for Cervical Cancer Screening, Introducing a Comfortable Alternative to In-Person Screening
Devices Diagnostics FDA

HSMN NewsFeed - 25 Aug 2021
BD Launches Fully Automated High-Throughput Molecular Diagnostic Platform for U.S. Laboratories
Diagnostics Product Launch

HSMN NewsFeed - 12 Aug 2020
MobileODT completed $4 million series round C
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 22 Jul 2020
BD receives FDA Approval for HPV Test with Extended Genotyping Capabilities
Diagnostics Oncology FDA

HSMN NewsFeed - 25 Apr 2018
FDA Approval of ThinPrep(R) Integrated Imager Expands Automated Imaging for Pap Testing to More Labs
Devices Diagnostics Oncology FDA

HSMN NewsFeed - 13 Feb 2018
FDA Approves New HPV Test that Detects and Identifies HPV Genotypes that put Women at High Risk for Cervical Cancer
Diagnostics FDA

HSMN NewsFeed - 6 Sep 2016
BD Submits Pre-Market Approval Application to FDA for BD Onclarity(TM) HPV Test
Diagnostics FDA

HSMN NewsFeed - 11 May 2016
Hologic Introduces the MyoSure(R) REACH Device to Help Physicians Access the Hard-to-Reach Upper Third of the Uterine Cavity
Devices Product Launch

HSMN NewsFeed - 24 Apr 2014
FDA Approves Roche's HPV Test for First-Line Primary Screening for Cervical Cancer
Diagnostics Oncology FDA

HSMN NewsFeed - 8 Apr 2014
Epic Sciences Appoints Pascal Bamford, Ph.D. as Vice President of Product Development
Diagnostics Personalized Medicine Oncology Personnel

HSMN NewsFeed - 16 Oct 2012
Hologic Announces FDA Approval of APTIMA HPV 16 18/45 Genotype Assay for Use on the TIGRIS System
Diagnostics Oncology FDA

HSMN NewsFeed - 25 Sep 2012
Gynecor, a Division of Bostwick Laboratories, Inc., Adds New State-of-the-Art Lab Technology to Help Physicians Identify Patients at Risk for Cervical Cancer, Improve Treatment Decisions
Diagnostics Oncology

HSMN NewsFeed - 25 Jul 2012
Guided Therapeutics and FDA Agree on Plan for LuViva(R) Advanced Cervical Scan PMA
Devices Diagnostics Oncology FDA

HSMN NewsFeed - 18 Jul 2012
Guided Therapeutics Notified of CE Mark Approval for LuViva(R) Advanced Cervical Scan
Devices Diagnostics Oncology Regulatory

HSMN NewsFeed - 17 Jul 2012
Hologic and Gen-Probe Announce Clearance from German Federal Cartel Office for Hologic's Acquisition of Gen-Probe
Devices Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 30 Apr 2012
Hologic to Acquire Gen-Probe
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 15 Mar 2012
Study Indicates Guided Therapeutics’ LuViva(R) Advanced Cervical Scan Could be used as an Initial Screen for Cervical Cancer
Devices Diagnostics Oncology

HSMN NewsFeed - 31 Oct 2011
FDA Approves Gen-Probe's APTIMA(R) HPV Assay, New Molecular Test to Detect Virus that Causes Cervical Cancer
Diagnostics Oncology FDA

HSMN NewsFeed - 19 Jul 2011
Roche acquires mtm laboratories AG, expanding offering in cervical cancer testing
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 1 Jul 2011
Merck Receives Approval to Market GARDASIL(R), ZOLINZA(R) and CUBICIN(R) in Japan
Biopharmaceuticals Regulatory

HSMN NewsFeed - 11 Feb 2011
Hologic Receives FDA Approval for First 3-D Digital Mammography (Breast Tomosynthesis) System
Devices Radiology FDA

HSMN NewsFeed - 8 Feb 2011
Hologic Targets Women's Health Professionals at ECR 2011
Devices Radiology Oncology

HSMN NewsFeed - 7 Jan 2011
Hologic Acquires Interlace Medical
Devices Surgery Mergers & Acquisitions

HSMN NewsFeed - 22 Dec 2010
US FDA Approves New Indication for Merck's HPV Vaccine, GARDASIL(R)
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 23 Nov 2010
Hologic Receives FDA Approvable Letter for Selenia Dimensions (3-D) Digital Mammography Tomosynthesis System
Devices Radiology Oncology FDA

HSMN NewsFeed - 25 Sep 2010
Hologic's Selenia Dimensions (3-D) Digital Mammography Tomosynthesis System Receives Favorable Votes From FDA Advisory Panel
Devices Radiology Oncology FDA

HSMN NewsFeed - 8 Jun 2010
IncellDx Secures $3 Million in Series A Financing
Diagnostics Venture Capital

HSMN NewsFeed - 11 May 2010
Hologic Unveils Next Generation NovaSure Endometrial Ablation System
Devices

HSMN NewsFeed - 17 Feb 2010
In Phase III Data Merck's GARDASIL(R) Was Efficacious Against Anal Disease Caused by HPV-6,11,16 and 18
Biopharmaceuticals

HSMN NewsFeed - 17 Oct 2009
FDA Approves GARDASIL(R) for Use in Boys and Young Men
Biopharmaceuticals FDA

HSMN NewsFeed - 29 Sep 2009
Hologic Receives CE Marking for the ThinPrep(R) Integrated Imager
Diagnostics Regulatory

HSMN NewsFeed - 1 Sep 2009
FDA Clears Hologic's MammoSite(R) ML Radiation Therapy System for the Treatment of Early-Stage Breast Cancer
Devices Oncology FDA

HSMN NewsFeed - 13 Mar 2009
FDA Approves Two Hologic HPV Tests
Diagnostics FDA

HSMN NewsFeed - 24 Feb 2009
Imalux(R) Corporation and Preventive Oncology International(R), Inc. Differentiate Grades of Pre-Invasive Cervical Dysplasia with Niris Optical Coherence Tomography Imaging System
Devices Diagnostics Oncology

HSMN NewsFeed - 9 Jan 2009
Merck & Co., Inc. Receives Complete Response Letter from the Food and Drug Administration for Use of GARDASIL(R) in Women Ages 27 through 45
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 13 Nov 2008
GARDASIL®, Merck's Cervical Cancer Vaccine, Demonstrated Efficacy in Preventing HPV-Related Disease in Males in Phase III Study
Biopharmaceuticals Oncology

HSMN NewsFeed - 17 Sep 2008
mtm laboratories Launches CINtec(R) Cytology Kit in Europe with Extended Clinical Claims for Cervical Cancer Diagnosis
Diagnostics Regulatory

HSMN NewsFeed - 25 Jun 2008
Merck & Co., Inc Receives Complete Response Letter from the Food and Drug Administration for Use of GARDASIL(R) in Women Ages 27 through 45
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 9 Jun 2008
Hologic to Acquire Third Wave Technologies
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 30 May 2008
Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus
Diagnostics Oncology

HSMN NewsFeed - 28 May 2008
Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus
Diagnostics

HSMN NewsFeed - 19 Mar 2008
Supplemental Application for GARDASIL(R), Merck's Cervical Cancer Vaccine, Designated Priority Review by the U.S. FDA for Use in Women 27 through 45
Biopharmaceuticals

HSMN NewsFeed - 22 Jan 2008
Hologic Announces Sale of Gestiva(TM)
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 13 Dec 2007
FDA Advisory Panel Finds Hologic's Adiana(R) Permanent Contraception Approvable
Devices FDA

HSMN NewsFeed - 20 Nov 2007
Health Canada Licenses QIAGEN's New Molecular Test for Hepatitis B
Diagnostics Regulatory

HSMN NewsFeed - 13 Nov 2007
CytoCore Announces Its Third International Distribution Agreement
Diagnostics Distribution

HSMN NewsFeed - 4 Nov 2007
New Data Presented on GARDASIL(R), Merck's Cervical Cancer Vaccine, in Women Through Age 45
Biopharmaceuticals Oncology

HSMN NewsFeed - 29 Oct 2007
Diamics Receives European CE Mark Approval for Its Pap-Map(TM) System for Cervical Cancer Screening
Diagnostics Regulatory

HSMN NewsFeed - 22 Oct 2007
Hologic and Cytyc Complete Merger
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 18 Oct 2007
Cytyc Stockholders Approve Hologic Merger
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 4 Oct 2007
Cytyc Ships Cellient(TM) Automated Cell Block Systems
Diagnostics

HSMN NewsFeed - 26 Sep 2007
Merck to Donate Three Million Doses of Gardasil(R), its Cervical Cancer Vaccine, to Support Vaccination Programs in Lowest Income Nations
Biopharmaceuticals Oncology

HSMN NewsFeed - 13 Sep 2007
Cytyc Sets Special Meeting of Stockholders to Vote on Proposed Merger with Hologic, Inc.
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 3 Jul 2007
Hologic and Cytyc Announce Expiration of Hart-Scott-Rodino Waiting Period
Devices Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 20 Jun 2007
Merck Provides Update on Status of Supplemental Biologics License Applications (sBLA) for GARDASIL(R)
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 21 May 2007
Hologic and Cytyc to Merge Creating a $10 Billion Global Leader in Women's Healthcare
Devices Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 17 May 2007
Data Published in The Lancet Show GARDASIL(R) was 100 Percent Effective in Preventing High-Grade Vulvar and Vaginal Lesions Caused by HPV Types 16 and 18
Biopharmaceuticals

HSMN NewsFeed - 9 May 2007
New England Journal of Medicine Publishes New Data on GARDASIL(R), Merck's Cervical Cancer Vaccine
Biopharmaceuticals Oncology

HSMN NewsFeed - 7 May 2007
Five-Year Results of Cytyc's MammoSite(R) Radiation Therapy System Presented at ASBS Annual Meeting
Devices Oncology

HSMN NewsFeed - 24 Apr 2007
Diamics Names Mitchell Golbus, MD, as Chief Medical and Technical Officer
Diagnostics Oncology Personnel

HSMN NewsFeed - 17 Apr 2007
Merck Submits New Cross-Protection Data for GARDASIL(R) to the FDA and Seeks New Indications for Vaginal and Vulvar Cancers
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 3 Apr 2007
Cytyc Acquires Adeza Biomedical Corporation
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 28 Mar 2007
Diamics Signs $22 Million Contract With Leading Hospital Group in China
Diagnostics Oncology

HSMN NewsFeed - 28 Mar 2007
Cytyc Announces New Multi-Year Agreement with Quest Diagnostics
Diagnostics

HSMN NewsFeed - 22 Mar 2007
CDC Finalizes Advisory Panel Recommendations for GARDASIL(R), Merck's Cervical Cancer Vaccine
Biopharmaceuticals

HSMN NewsFeed - 21 Mar 2007
Diamics Receives FDA Clearance for Revolutionary New Cervical Sample Collection System
Devices Diagnostics Oncology FDA

HSMN NewsFeed - 16 Mar 2007
Cytyc Corporation Completes Acquisition of Adiana, Inc.
Devices Mergers & Acquisitions

HSMN NewsFeed - 14 Mar 2007
Cytyc Corporation Announces Expiration of Antitrust Waiting Period for Adeza Biomedical Corporation Tender Offer
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 27 Feb 2007
Cytyc to Acquire Adiana, Inc.
Devices Mergers & Acquisitions

HSMN NewsFeed - 12 Feb 2007
Cytyc to Acquire Adeza Biomedical Corporation
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 30 Jan 2007
Cytyc Announces New UK NICE Clinical Guideline Recommends Endometrial Ablation Instead of Hysterectomy For Most Women with Heavy Menstrual Bleeding
Devices

HSMN NewsFeed - 15 Nov 2006
Eight Studies Evaluating Cytyc's Novasure(R) System Presented at AAGL Meeting
Devices

HSMN NewsFeed - 14 Nov 2006
Daryl J. Faulkner Appointed Chief Executive Officer and Director of Digene
Diagnostics Personnel

HSMN NewsFeed - 13 Nov 2006
Twelve Studies Evaluating Cytyc's MammoSite(R) Radiation Therapy System Presented at ASTRO Annual Meeting
Devices Oncology

HSMN NewsFeed - 13 Nov 2006
Merck Launches National Advertising Campaign for GARDASIL(R), Merck's New Cervical Cancer Vaccine
Biopharmaceuticals

HSMN NewsFeed - 1 Nov 2006
Merck's Cervical Cancer Vaccine, GARDASIL(R), Added to the CDC Vaccines for Children Contract
Biopharmaceuticals Oncology

HSMN NewsFeed - 25 Oct 2006
Cytyc to Introduce Cellient(TM) Automated Cell Block System at American Society of Cytopathology Annual Meeting
Devices Diagnostics

HSMN NewsFeed - 25 Oct 2006
Cytyc Acquires Minimally Invasive Surgical Device for Treating Endometriosis
Devices Surgery Acquisitions

HSMN NewsFeed - 5 Oct 2006
Cytyc Statement on Termination of Merger Implementation Agreement between Vision Systems and Ventana
Devices Diagnostics Oncology Mergers & Acquisitions

HSMN NewsFeed - 28 Sep 2006
California to Require Insurers to Cover HPV Testing in Cervical Cancer Screening
Diagnostics Oncology Reimbursement

HSMN NewsFeed - 22 Sep 2006
European Commission Approves GARDASIL(R), Merck's Cervical Cancer Vaccine
Biopharmaceuticals Regulatory

HSMN NewsFeed - 8 Sep 2006
BD to Acquire TriPath Imaging, Inc.
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 24 Jul 2006
CytoCore, Inc. Announces New Cancer Screening and Treatment System On The Horizon
Diagnostics Oncology

HSMN NewsFeed - 19 Jul 2006
TriPath Imaging, Inc. Announces Promotions of Johnny D. Powers, Ph.D. to President, TriPath Oncology and James D. Petrilla to Senior Vice President, Commercial Operations
Diagnostics Oncology Personnel

HSMN NewsFeed - 29 Jun 2006
Merck's New Cervical Cancer Vaccine, GARDASIL(R), Unanimously Recommended by CDC Advisory Panel for Vaccination of Girls and Women 11 to 26 Years
Biopharmaceuticals Oncology

HSMN NewsFeed - 15 May 2006
New Study Reports on Improved Disease Detection with the ThinPrep(R) Imaging System
Diagnostics

Return to NewsFeed

Additional items found! 78

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 78 additional stories matching:
cervical cancer screening
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.